Results 131 to 140 of about 3,878 (166)

Levosimendan: Implications for Clinicians

The Journal of Clinical Pharmacology, 2003
Levosimendan is a novel calcium sensitizing agent in development for the treatment of acute and chronic heart failure. The agent increases myocardial force without increasing myocyte calcium concentrations, thus reducing the possibility for myocardial necrosis.
Brian F, McBride, C Michael, White
openaire   +2 more sources

Levosimendan

Reactions Weekly, 2017
Vidyut Jain, Avani Jain
  +4 more sources

Levosimendan

Reactions Weekly, 2016
Massimiliano Greco, Gianluca Paternoster, Daniela Mamo   +2 more
  +4 more sources

Levosimendan

DMW - Deutsche Medizinische Wochenschrift, 2005
G, Michels, S, Herzig, U C, Hoppe
openaire   +2 more sources

Levosimendan

Reactions Weekly, 2023
openaire   +2 more sources

The importance of pharmacokinetics, pharmacodynamic and repetitive use of levosimendan

Biomedicine and Pharmacotherapy, 2022
Grzegorz Grzesk, Daniel Rogowicz, Łukasz Wołowiec   +2 more
exaly  

Levosimendan

Reactions Weekly, 2022
openaire   +1 more source

Levosimendan

Intensive and Critical Care Nursing, 2003
openaire   +2 more sources

Levosimendan and Cardiac Surgery

Journal of Cardiothoracic and Vascular Anesthesia, 2010
DE SANTIS V, VITALE D, TRITAPEPE, Luigi
openaire   +3 more sources

Levosimendan

Reactions Weekly
  +5 more sources